These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10602015)

  • 1. Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo.
    Munthe LA; Kyte JA; Bogen B
    Eur J Immunol; 1999 Dec; 29(12):4043-52. PubMed ID: 10602015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic autoimmune disease caused by autoreactive B cells that receive chronic help from Ig V region-specific T cells.
    Munthe LA; Corthay A; Os A; Zangani M; Bogen B
    J Immunol; 2005 Aug; 175(4):2391-400. PubMed ID: 16081810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation by processed immunoglobulin on B-cells.
    Ghosh SK; Chakrabarti D
    Indian J Biochem Biophys; 1993 Dec; 30(6):414-21. PubMed ID: 7911781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
    Dembic Z; Schenck K; Bogen B
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells.
    Jacobsen J; Haabeth OA; Tveita AA; Schjetne KW; Munthe LA; Bogen B
    J Immunol; 2014 May; 192(9):4174-83. PubMed ID: 24706724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mouse model for immunotherapy of myeloma.
    Bogen B
    Hematol J; 2002; 3(5):224-9. PubMed ID: 12391539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: to what extent are T cells tolerant to immunoglobulin variable regions?
    Bogen B; Ruffini P
    Scand J Immunol; 2009 Dec; 70(6):526-30. PubMed ID: 19906193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG.
    Hestvik AL; Vartdal F; Fredriksen AB; Thompson KM; Kvale EO; Skorstad G; Bogen B; Holmoy T
    Scand J Immunol; 2007 Oct; 66(4):393-401. PubMed ID: 17850583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo.
    Lundin KU; Screpanti V; Omholt H; Hofgaard PO; Yagita H; Grandien A; Bogen B
    Cancer Immunol Immunother; 2004 Dec; 53(12):1135-45. PubMed ID: 15696611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin-specific T-B cell interaction. IV. B cell presentation of idiotypic determinant(s) of monoclonal anti-surface immunoglobulin antibody to idiotope-recognizing helper T clones.
    Rudensky AY; Mazel SM; Blechman JM; Yurin VL
    Eur J Immunol; 1990 Aug; 20(8):1691-6. PubMed ID: 2120062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-restricted Ig V region-driven T-B lymphocyte collaboration: B cell receptor ligation facilitates switch to IgG production.
    Munthe LA; Os A; Zangani M; Bogen B
    J Immunol; 2004 Jun; 172(12):7476-84. PubMed ID: 15187126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation.
    Jacobsen JT; Lunde E; Sundvold-Gjerstad V; Munthe LA; Bogen B
    Immunol Cell Biol; 2010 Jul; 88(5):515-22. PubMed ID: 20066000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma.
    Bogen B
    Eur J Immunol; 1996 Nov; 26(11):2671-9. PubMed ID: 8921954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Igh-1b-specific CD4+CD8- T cell clones of the Th1 subset selectively suppress the Igh-1b allotype in vivo.
    Bartnes K; Hannestad K
    Eur J Immunol; 1991 Oct; 21(10):2365-71. PubMed ID: 1680695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T lymphocyte response to syngeneic lambda 2 light chain idiotopes. Significance of individual amino acids revealed by variant lambda 2 chains and idiotope-mimicking chemically synthesized peptides.
    Hannestad K; Kristoffersen G; Briand JP
    Eur J Immunol; 1986 Aug; 16(8):889-93. PubMed ID: 2943595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II-restricted presentation of an immunoglobulin heavy-chain-gene product by a gene-transfected B-cell line.
    Matsuura Y; Onishi S; Yamamoto Y; Taniguchi T; Obana S; Yamamoto H
    Jpn J Med Sci Biol; 1994 Aug; 47(4):195-210. PubMed ID: 7715093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models.
    Corthay A; Lundin KU; Munthe LA; Frøyland M; Gedde-Dahl T; Dembic Z; Bogen B
    Cancer Immunol Immunother; 2004 Sep; 53(9):759-69. PubMed ID: 15088126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.